AuthorsOlendzki, Barbara C.
KeywordsInflammatory Bowel Disease
Dietetics and Clinical Nutrition
Digestive System Diseases
Translational Medical Research
MetadataShow full item record
AbstractMounting evidence suggests that particular aspects of human health and disease may be attributable to the trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota. Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is a major area of research interest. As part of the mini-symposium entitled "Manipulating the Gut Microbiome for Human Health," Dr. Olendzki presents on the Inflammatory Bowel Disease Anti-Inflammatory Diet (IBD-AID).
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/28025
Presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.
RightsCopyright the Author(s)